Neurolens and Contact Lens Discomfort

NCT ID: NCT05801991

Last Updated: 2025-04-22

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 30 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-05-01
• Study Completion Date: 2024-03-05

Brief Summary

The objective of this study is to determine how neurolens® influences contact lens discomfort in uncomfortable myopic soft contact lenses wearers. It is hypothesized that uncomfortable soft contact lens wearers are experiencing some level of discomfort associated with increased vergence demand when looking at near targets and will experience discomfort relief when wearing neurolens® over their habitual soft contact lenses. Uncomfortable, myopic soft contact lens wearers will be recruited. Each participant will be masked and randomly assigned a placebo pair of spectacles or a neurolens® spectacle pair for approximately one month. A prospective, randomized clinical trial will be performed. Participants and investigators will be masked to the treatment.

Detailed Description

Discomfort is the primary reason for contact lens dissatisfaction and discontinuation. Symptoms of contact lens discomfort are often attributed to dryness; however, severity of dry eye and discomfort symptoms is not correlated with clinical dry eye severity. When clinical signs of contact lens discomfort and dryness misalign with symptom severity, the possibility of an under-recognized etiology must be considered.

Symptoms associated with contact lens discomfort are similar to symptoms reported with binocular vision disorders and accommodative and vergence strain. Eyestrain, fatigue, and increased/more frequent end-of-day symptoms are noted by patients in both groups of conditions. It has been reported that uncomfortable contact lens wearers have an unusually high prevalence of binocular vision disorders and clinical signs. Basic optical calculations show that myopes must converge and accommodate more when corrected with contact lenses versus spectacles, so it is reasonable to hypothesize that a myopic contact lens wearer may experience eyestrain and discomfort associated with vergence fatigue while wearing contact lenses, but not while wearing single vision spectacles.

neurolens® is a type of spectacle lens that uses contoured prism to alleviate vergence demands and fatigue at near and, therefore, encourages comfortable vision. This spectacle design uses the neurolens® Measurement Device (nMD) to measure eye alignment and determine the spectacle lenses that are uniquely designed for each wearer. Acknowledging that some amount of contact lens discomfort may be caused by vergence fatigue, it is possible that uncomfortable contact lens wearers who wear neurolens® over their contact lenses will achieve discomfort relief.

The objective of this study is to determine how neurolens® influences contact lens discomfort in uncomfortable myopic soft contact lenses wearers. Investigators hypothesize that uncomfortable soft contact lens wearers are experiencing some level of discomfort associated with increased vergence demand when looking at near targets and will experience discomfort relief when wearing neurolens® over their habitual soft contact lenses. Uncomfortable, myopic soft contact lens wearers will be recruited. Each participant will be masked and randomly assigned a placebo pair of spectacles or a neurolens® spectacle pair for approximately one month. A prospective, randomized clinical trial will be performed. Participants and investigators will be masked to the treatment.

Conditions

Contact Lens Discomfort

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Neurolens Treatment

Participants will receive Neurolens lenses (measured with the Neurolens device while wearing their habitual contact lenses) in their study spectacles

Group Type: EXPERIMENTAL

Neurolens

Intervention Type: DEVICE

neurolens® is a type of spectacle lens that uses contoured prism to alleviate vergence demands and fatigue at near and, therefore, encourages comfortable vision.8 This spectacle design uses the neurolens® Measurement Device (nMD) to measure eye alignment and determine the spectacle lenses that are uniquely designed for each wearer.

Placebo Lens

Participants will receive plano (no power) lenses in their study spectacles

Group Type: PLACEBO_COMPARATOR

Placebo spectacle lens

Intervention Type: DEVICE

Plano (no power) spectacle lenses will be assigned to the placebo group

Interventions

Neurolens

neurolens® is a type of spectacle lens that uses contoured prism to alleviate vergence demands and fatigue at near and, therefore, encourages comfortable vision.8 This spectacle design uses the neurolens® Measurement Device (nMD) to measure eye alignment and determine the spectacle lenses that are uniquely designed for each wearer.

Intervention Type: DEVICE

Placebo spectacle lens

Plano (no power) spectacle lenses will be assigned to the placebo group

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Uncomfortable soft contact lens wearers (CLDEQ-8 ≥ 17 points)
• Adult, pre-presbyopic age range (18 - 35 years)
• Visual acuity of 20/25 or better in each eye with habitual contact lenses
• Soft, spherical or low toric, single vision soft contact lens wearer:

• Habitual contact lens sphere power -0.75 D or more myopic
• Habitual contact lens are spherical design or have 1.75 D or less of cylinder correction
• Habitual soft contact lenses are single vision design
• Valid contact lens prescription at the date of the baseline
• No significant subjective over-refraction in either eye with habitual soft contact lenses
• No significant subjective over-refraction in either eye with habitual soft contact lenses

• Sphere: ≤ 0.50 D myopia, ≤ 0.50 D hyperopia
• Cylinder: ≤ 0.75 D
• Valid measurement on the neurolens® Measurement Device (nMD2)

• A numerical neurolens value
• No low Measurement Quality Index (MQI) < 0.8 or convergence excess

Exclusion Criteria

• History of ocular surgery
• History of ocular disease, amblyopia, strabismus, or vision therapy
• History of neurolens or prism spectacle correction
• History of significant vertical phoria or vertical phoria correction
• Current ocular medication use
• Significant signs of dry eye:

• > Grad 1 ocular surface staining
• Schirmer scores < 7 mm
• Tear break up time < 7 seconds
• Signs of inappropriate fit or surface of soft contact lenses

• Insufficient movement centration, and/or coverage
• Significant lens deposits
• Signs of corneal or conjunctival contact-lens related complications

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Neurolens Inc.

INDUSTRY

Sponsor Role: collaborator

Southern California College of Optometry at Marshall B. Ketchum University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Erin Rueff, OD, PhD

Role: PRINCIPAL_INVESTIGATOR

Marshall B. Ketchum University

Locations

The Southern California College of Optometry at Marshall B. Ketchum University

Fullerton, California, United States

Countries

United States

Provided Documents

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

SCCOCLNeurolens

Identifier Type: -

Identifier Source: org_study_id